Non-interventional study to capture data on the use of a VWF/FVIII concentrate (wilate) in all clinical settings of von Willebrand disease including health-related quality of life
Latest Information Update: 17 Feb 2022
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- Acronyms wilate-NEWS
- Sponsors Octapharma
Most Recent Events
- 17 Feb 2022 New trial record